ES2118090T3 - Nuevo uso medico de un determinado derivado de indol y composicion farmaceutica que lo contiene. - Google Patents

Nuevo uso medico de un determinado derivado de indol y composicion farmaceutica que lo contiene.

Info

Publication number
ES2118090T3
ES2118090T3 ES91917473T ES91917473T ES2118090T3 ES 2118090 T3 ES2118090 T3 ES 2118090T3 ES 91917473 T ES91917473 T ES 91917473T ES 91917473 T ES91917473 T ES 91917473T ES 2118090 T3 ES2118090 T3 ES 2118090T3
Authority
ES
Spain
Prior art keywords
medical use
pct
new medical
indol
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91917473T
Other languages
English (en)
Inventor
Alison Jane Pilgrim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2118090T3 publication Critical patent/ES2118090T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

LA PRESENTE INVENCION SE REFIERE A UN NUEVO USO MEDICO DE 3-[2(DIMETILAMINO)-ETIL]-N-METIL-1H-INDOL-5-METANOSULFONAMIDAS Y DE LAS SALES FISIOLOGICAMENTE ACEPTABLES Y LOS SOLVATOS DE LAS MISMAS PARA EL TRATAMIENTO DE DOLORES DE CABEZA DEL TIPO QUE SE PRODUCEN POR UN ESTADO DE TENSION Y A DOLORES DE CABEZA ASOCIADOS A SUSTANCIAS O A LA RETIRADA DE LAS MISMAS.
ES91917473T 1990-10-12 1991-10-11 Nuevo uso medico de un determinado derivado de indol y composicion farmaceutica que lo contiene. Expired - Lifetime ES2118090T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909022250A GB9022250D0 (en) 1990-10-12 1990-10-12 Medicaments

Publications (1)

Publication Number Publication Date
ES2118090T3 true ES2118090T3 (es) 1998-09-16

Family

ID=10683660

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91917473T Expired - Lifetime ES2118090T3 (es) 1990-10-12 1991-10-11 Nuevo uso medico de un determinado derivado de indol y composicion farmaceutica que lo contiene.

Country Status (16)

Country Link
US (1) US5376672A (es)
EP (1) EP0552205B1 (es)
JP (1) JP3159263B2 (es)
KR (1) KR0178762B1 (es)
AT (1) ATE168006T1 (es)
AU (1) AU660153B2 (es)
CA (1) CA2093527A1 (es)
DE (1) DE69129750T2 (es)
DK (1) DK0552205T3 (es)
ES (1) ES2118090T3 (es)
GB (1) GB9022250D0 (es)
IE (1) IE913580A1 (es)
IL (1) IL99715A (es)
TW (1) TW212756B (es)
WO (1) WO1992006688A1 (es)
ZA (1) ZA918117B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0737074B1 (en) * 1993-12-28 2001-08-01 Allergan Sales, Inc. Botulinum toxins for treating hyperhydrosis
MX9703988A (es) * 1994-12-12 1998-02-28 Omeros Med Sys Inc SOLUCIaN Y MÉTODO DE IRRIGACIaN PARA LA INHIBICIaN DEL DOLOR, LA INFLAMACIaN Y ES ESPASMO.
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
EP1765300A2 (en) * 2004-06-10 2007-03-28 Duramed Pharmaceuticals, Inc. Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
CA2665841C (en) 2006-10-09 2016-04-05 Charleston Laboratories, Inc. Pharmaceutical compositions
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
US8304179B2 (en) * 2009-05-11 2012-11-06 Taiwan Semiconductor Manufacturing Company, Ltd. Method for manufacturing a semiconductor device using a modified photosensitive layer
US20100287502A1 (en) * 2009-05-11 2010-11-11 Olympus Imaging Corp. Image search device and image search method
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GR79215B (es) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative

Also Published As

Publication number Publication date
TW212756B (es) 1993-09-11
ATE168006T1 (de) 1998-07-15
DE69129750D1 (de) 1998-08-13
EP0552205B1 (en) 1998-07-08
DE69129750T2 (de) 1998-11-12
US5376672A (en) 1994-12-27
WO1992006688A1 (en) 1992-04-30
KR0178762B1 (ko) 1999-03-20
AU8642291A (en) 1992-05-20
IE913580A1 (en) 1992-04-22
AU660153B2 (en) 1995-06-15
JPH06501935A (ja) 1994-03-03
EP0552205A1 (en) 1993-07-28
CA2093527A1 (en) 1992-04-13
IL99715A0 (en) 1992-08-18
JP3159263B2 (ja) 2001-04-23
GB9022250D0 (en) 1990-11-28
ZA918117B (en) 1992-08-26
DK0552205T3 (da) 1999-04-19
IL99715A (en) 1996-01-19

Similar Documents

Publication Publication Date Title
TR199902253T2 (xx) �n g�z odac���nda farmas�tik maddelerin kontroll� sal�n�m�.
CO4340681A1 (es) Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
IT1274879B (it) Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
DE69812159T2 (de) Derivate des adamantan
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
MY112915A (en) Multiple unit tableted dosage form 1
NO20002786L (no) Adamantanderivater
DK0706378T3 (da) Ny farmaceutisk formulering.
ES2118090T3 (es) Nuevo uso medico de un determinado derivado de indol y composicion farmaceutica que lo contiene.
SE9402816D0 (sv) Method and meams for drug administration
PT741716E (pt) Analogos de delta 12,13-iso-taxol sua utilizacao anti-neoplasica e composicoes farmaceuticas que os contem
CY1118924T1 (el) Μεθοδος για θεραπεια της πρωτοπαθους αϋπνιας
DK0678026T3 (da) Anvendelse af carbamazepin og oxcarbazepin ved fremstilling af lægemidler til behandling af Parkinsons sygdom og parkinsonisme-syndromer
ES2185660T3 (es) Nuevo uso de dexmedetomidina.
ZA965969B (en) Salts derived from amidine and cyclooxygenase inhibitor process for the preparation thereof their application as medicinal drugs and pharmaceutical compositions in which they are contained
DE69226649D1 (de) Analoge des menschlichen Interleukin-8.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
SE9402880D0 (sv) New peptide derivatives
UY27753A1 (es) Formulación farmacéutica que comprende melatonina.
NZ241234A (en) Amino polyhydroxy cyclohexane derivatives and medicaments
HUT77175A (hu) Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására és szelegilint tartalmazó epilepsziaellenes gyógyszerkészítmények
ES2175424T3 (es) Sal de metansulfonato de una arilpiperazina derivada de triptamina y sus solvatos para uso farmaceutico.
SE9404438D0 (sv) New process
HK1005651A1 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 552205

Country of ref document: ES